openPR Logo

Press Releases from Kuick Resarch (925 total)

Targeted Alpha Therapy Market

Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: • Global Targeted Alpha Therapy Market Insight By Region • Approved Targeted

Global Cancer Antibody Drug Conjugates Market

Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: • Global Cancer Antibody Drug Conjugates Market:

Cancer Peptide Drugs Market

Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region &

Bispecific Antibody Drug Conjugates Development

The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity

Breakthroughs in KRAS Inhibitor Research

KRAS mutations have posed a significant challenge in oncology for decades, but recent breakthroughs in KRAS inhibitor research have sparked hope for new cancer therapies.

Lumakras Drug Clinical Insight and Sales Forecast 2026

"Lumakras Drug Clinical Insight and Sales Forecast 2026" Report Highlights: * NSCLC Targeting Lumakras Market Opportunity (US$ Million) * Colorectal Cancer Targeting Lumakras Market Opportunity (US$ Million) *

Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026

"Global EZH2 Inhibitor Market Opportunity, Sales and Clinical Trials Insight 2026" Report Highlights: * Global EZH2 Inhibitor Market Opportunity > US$ 1.2 Billion by 2026 * Tazverik

Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Tr …

"Global Bispecific Antibody Market Opportunity, Drug Sales, Price and Clinical Trials Insight 2028" Report Highlights: * Global Bispecific Antibody Market Opportunity: > US$ 20 Billion *

Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and C …

"Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * Global FGFR Inhibitors Market Opportunity: > USD 4 Billion

Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026

"Europe Biosimilars Market, Dosage, Price, Sales and Clinical Trials Insight 2026" Report highlights: * Europe Biosimilars Market Opportunity: > USD 10 Billion * Dosage and Pricing insight

US Biosimilar Insulin Market Opportunity and Clinical Trials Insight 2026

"US Biosimilar Insulin Market Opportunity and Clinical Trials Insight 2026" Report Highlights: * US Diabetic Drug Market Opportunity: > US$ 35 Billion * US Insulin Market Opportunity

Global Cell Therapy Market Outlook, Patent and Clinical Trials Insight 2028

"Global Cell Therapy Market Outlook, Patent and Clinical Trials Insight 2028" Report Highlights: * Global Cell Therapy Market Opportunity: > USD 45 Billion By 2028 *

Global PDGFR Inhibitors Market, Drug Sales and Clinical Trials Insight 2026

Global PDGFR Inhibitors Market, Drug Sales and Clinical Trials Insight 2026 Report Analysis and Data Highlights: * Research Methodology * Global and Regional Market Analysis * Global PDGFR

Global MEK Inhibitors Market, Drug Sales and Clinical Trials insight 2026

Global MEK Inhibitors Market, Drug Sales and Clinical Trials insight 2026 Report Analysis and Data Highlights: * Research Methodology * Global and Regional Market Analysis * Global MEK

Ayvakit Patent, Sales and Clinical Trials Insight 2028

Ayvakit Patent, Sales and Clinical Trials Insight 2028 Report Analysis and Data Highlights: * Ayvakit Patent Insight * Ayvakit Dosage and Price * Ayvakit Sales Forecast 2028:

Danyelza Patent, Sales and Clinical Trials Outlook 2028

Danyelza Patent, Sales and Clinical Trials Outlook 2028 Report Analysis and Data Highlights: * Danyelza Patent Insight * Danyelza Dosage and Price * Danyelza Sales Forecast 2028:

Rybrevant Bispecific Antibody Patent, Sales and Clinical Trials Outlook 2028

Rybrevant Bispecific Antibody Patent, Sales and Clinical Trials Outlook 2028 Report Analysis and Data Highlights: * Rybrevant Patent Insight * Rybrevant Dosage and Price * Rybrevant Sales

Trikafta Patent, Sales and Clinical Trials Insight 2028

Trikafta Patent, Sales and Clinical Trials Insight 2028 Report Analysis and Data Highlights: * Trikafta Patent Insight * Trikafta Dosage and Price * Trikafta Sales Forecast 2028: >

Unituxin Patent, Sales and Clinical Trials Outlook 2028

Unituxin Patent, Sales and Clinical Trials Outlook 2028 Report Analysis and Data Highlights: * Unituxin Patent Insight * Unituxin Dosage and Price * Unituxin Sales Forecast 2028:

Trodelvy Patent, Sales and Clinical Trials Insight 2028

Trodelvy Patent, Sales and Clinical Trials Insight 2028 Report Analysis and Data Highlights: * Trodelvy Patent Insight: 29 Patents * Trodelvy Dosage and Price *

Global TRK Inhibitors Market, Drug Sales and Clinical Trials insight 2026

Global TRK Inhibitors Market, Drug Sales and Clinical Trials Insight 2026 Report Analysis and Data Highlights: * Research Methodology * Global and Regional Market Analysis * Global TRK

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market and Clinical Tri …

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market and Clinical Trials Insight 2026 Report Analysis and Data Highlights: * Research Methodology * Global and Regional Market

Global TROP2 Antibody Market and Clinical Trials Insight 2026

Global TROP2 Antibody Market and Clinical Trials Insight 2026 Report Analysis and Data Highlights: * Research Methodology * Global and Regional Market Analysis * Global TROP2 Antibody Market

Global Trispecific Antibody Market Opportunity and Clinical Trials Insight 2028

Global Trispecific Antibody Market Opportunity and Clinical Trials Insight 2028 Report Analysis and Data Highlights: * Research Methodology * Global Market Analysis * Global Trispecific Antibody Market Opportunity

Global TIGIT Inhibitor Drug Opportunity and Clinical Research Insight 2022

Global TIGIT Inhibitor Drug Opportunity and Clinical Research Insight 2022 Report Highlights: * Global TIGIT Inhibitor Market Dynamics * Clinical Approaches to Target TIGIT * Role of TIGIT

Global LAG 3 Inhibitor Clinical Trials and Market Opportunity Insight 2028

Global LAG 3 Inhibitor Clinical Trials and Market Opportunity Insight 2028 Report Highlights: * Global LAG 3 Inhibitors Market Dynamics * Clinical Approaches to Target LAG 3

Global LAG 3 Inhibitor Clinical Trials and Market Opportunity Insight 2028

Global LAG 3 Inhibitor Clinical Trials and Market Opportunity Insight 2028 Report Highlights: * Global LAG 3 Inhibitors Market Dynamics * Clinical Approaches to Target LAG 3

US Cancer Antibodies Market, Drug Sales, Patent and Clinical Trials Outlook 2028

US Cancer Antibodies Market, Drug Sales, Patent and Clinical Trials Outlook 2028 Report Highlights: * US Cancer Antibodies Market Opportunity: > US$ 85 Billion by 2028 *

Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2028

Global Transdermal Patch Market, Dosage, Price and Clinical Trials Insight 2028 Report Highlights: * Research Methodology * Global and Regional Transdermal Path Market Outlook * Global Transdermal Patch

Global Cancer Antibody Drug Conjugate Market, Price, Dosage and Clinical Trials …

Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, and Clinical Trials Insight 2028 Report Highlights: * Global Cancer Antibody Drug Conjugate Market Opportunity > USD

Global Immune Checkpoint Inhibitors Biomarkers and Clinical Trials Insight 2028

Global Immune Checkpoint Inhibitors Biomarkers and Clinical Trials Insight 2028 Report Highlights: * Global Immune Checkpoint Inhibitors Market Opportunity: > USD 30 Billion * Immune Checkpoint Inhibitors

Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Ou …

Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028 Report Highlights: * Global Nanoparticle Drug Delivery Market Opportunity > USD 300 Billion by

Home DNA Test Kit Market Opportunity Forecast 2028

Home DNA Test Kit Market Opportunity Forecast 2028 Report Highlights: * Global Home DNA Test Kit Market Opportunity > USD 10 Billion * US Dominating Global DNA

Global Bcr Abl Inhibitor Market, Drug Sales and Clinical Trials Insight 2028

Global Bcr-Abl Inhibitor Market, Drug Sales and Clinical Trials Insight 2028 Report Highlights: * Global Bcr-Abl Inhibitor Market Opportunity > USD 8 Billion * Approved Bcr-Abl Inhibitor

Global KRAS Inhibitors Market and Clinical Trials Forecast 2028

"Global KRAS Inhibitors Market and Clinical Trials Forecast 2028" Report Highlights: * KRAS Inhibitors Market Opportunity: > USD 4.5 Billion by 2028 * Initially US To Dominate

Gamma Delta T Cell Cancer Therapy Market and Clinical Trials Forecast 2028

"Gamma Delta T Cell Cancer Therapy Market and Clinical Trials Forecast 2028" Report Highlights: * Commercialization Market Potential After Market Launch: > USD 4 Billion * Insight

Global PARP Inhibitors Cancer Therapy Market and Clinical Trials Insight 2028

Global PARP Inhibitors Cancer Therapy Market and Clinical Trials Insight 2028 Report Highlights: * Global PARP Inhibitors Cancer Therapy Market Opportunity: > USD 6 Billion * Commercially

Global Lymphoma Antibodies Market and Clinical Trials Insight 2028

"Global Lymphoma Antibodies Market and Clinical Trials Insight 2028" Report Highlights: * Global Lymphoma Antibodies Market Opportunity: >USD 5 Billion * Global Lymphoma Antibodies Market Insights: Current,

Global CFTR Modulators Market Opportunity, Drug Sales and Clinical Trials Insigh …

Global CFTR Modulators Market Opportunity, Drug Sales and Clinical Trials Insight 2028 Report Insight: * Global CFTR Modulators Market Opportunity: > USD 25 Billion * Global CFTR

Global CAR T Cell Therapy Market and Clinical Trials Insight 2028

Global CAR T Cell Therapy Market and Clinical Trials Insight 2028 Report Highlights: * Global CAR T Cell Therapy Market Opportunity > USD 15 Billion *

Global Orphan Drug Rare Disease Market Clinical Trials Forecast 2028

Global Orphan Drugs Clinical Trials Insight Report Highlights: • Clinical Insight On More Than 400 Marketed Orphan Drugs • Clinical Insight On More Than 1300 Orphan Drugs

Global CD233 Antibody Market Clinical Trials Intelligence 2028

Global CD233 Inhibitors Trials Intelligence Report Highlights: • Global CD233 Inhibitors Market Dynamics • Clinical Approaches to Target CD233 Inhibitors • Role of CD233 Inhibitors in Cancer,

Global Gene Therapy Market Clinical Trials Research Insight 2028

Global Gene Therapy Market & Clinical Trials Intelligence Report Highlights • Global Market Gene Therapy Landscape USD 24 Billion Opportunity • Comprehensive Commercial & Clinical insight on

TROP2 Targeted Therapy Trodelvy Market Clinical Trials Insight 2026

Global TROP2 Antibody Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global TROP2 Antibody Market Opportunity Assessment:

Global Fibroblast Growth Factor Receptor FGFR Cancer Therapy Market Clinical Tri …

Global Fibroblast Growth Factor Receptor Inhibitor Drug Market Opportunity and Clinical Trials Insight 2026 Report Highlights: • Global FGFR Inhibitors Market Opportunity: > USD 4 Billion

Clinical Trials Advances And Challenges in Bispecific and Trispecific Antibodies …

In recent years, healthcare sector has witnessed emergence of several promising multispecific antibodies which have revolutioned the management of several chronic disorders, including cancer. Multispecific

Global CFTR Modulators Market Opportunity Clinical Trials Insight 2026

“Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2026” Report Highlights: • Global CFTR Modulators Market Opportunity: > US$ 20 Billion • Global CFTR

Gamma Delta T Cell Cancer Therapy Opportunity Clinical Trials Insight 2026

“Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” Report Highlights: • Commercialization Market Potential After Market Launch: > USD 4 Billion • Insight on Key

Global Peptide Drug Conjugate Clinical Trial Report 2026

Global Peptide Drug Conjugate Market & Clinical Trials Insight 2026 Report Highlights: • First FDA Approved Peptide Drug Conjugate: Pepaxto (Melphalan Flufenamide) • Pepaxto Clinical & Commercial Insight: Dosage,

Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024

"Global Trispecific Antibodies Market Opportunity & Clinical Trials Insight 2024" Report Highlights: • Commutative Market Opportunity During Initial 5 years of Commercialization: > US$ 2 Billion • Trispecific

Go To Page:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18